Revenue in the same period was up 6% y-o-y to RM4.1 billion as the company saw growth in its key markets, with a rebound in domestic patient revenue, contribution from delivery of Covid-19 related services and a continued ramp-up of operations at Gleneagles Hong Kong Hospital (GHK).
Hospital operator IHH Healthcare has reported earnings of RM493 million ($154.8 million), up 31% y-o-y for its 1QFY2022 ended March 31.
This translates to a basic earnings per share (EPS) of 5.36 sen for the quarter, compared to EPS of 4.04 sen a year ago.
